{
  "pmcid": "7399295",
  "sha256": "bca4f15a70aded456082945c4244ae5ce451dcb71cab0a61e926bc5c0c4b1e66",
  "timestamp_utc": "2025-11-10T00:05:56.950252+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 14.056823960353373,
    "reading_ease": 22.884744667097635,
    "word_count": 273
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "The EMPATHY Study: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomly assigned in a 1:1 ratio"
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligible patients had elevated low-density lipoprotein cholesterol (LDL-C) and diabetic retinopathy."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomly assigned in a 1:1 ratio to receive either intensive or standard statin therapy."
      },
      "Objective": {
        "score": 1,
        "evidence": "The EMPATHY study investigates whether intensive statin therapy is more effective than standard therapy in reducing cardiovascular events in patients with hyperlipidemia and diabetic retinopathy."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was a composite of CVD incidence and CVD-related death, measured over a maximum follow-up period of 5.5 years."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, with allocation concealment ensured."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Outcome assessors were blinded to treatment allocation."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 5,144 patients were randomised, with 2,571 assigned to intensive therapy and 2,573 to standard therapy."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Baseline data were analysed for 5,107 patients (2,550 in the intensive therapy group and 2,557 in the standard therapy group) using an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 0,
        "evidence": "The effect size and precision of the primary outcome are detailed in the full manuscript."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were monitored, with no significant differences reported between groups."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: UMIN000003486."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding sources are disclosed in the full manuscript."
      }
    },
    "total_score": 17,
    "max_score": 25
  }
}